Patents-Review.com
ClassID:

21127 ⎘

A61K39/23 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Viral antigens Parvoviridae, e.g. feline panleukopenia virus

Recent Application in this class:
#1
20260069672
2026-03-12

Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof

 #2
20250352626
2025-11-20

IMMUNE TOLERANCE INDUCTION TO VIRAL CAPSIDS

 #3
20250352594
2025-11-20

Yeast Platform for the Production of Vaccines

 #4
20250262296
2025-08-21

MODIFIED ONCOLYTIC PARVOVIRUS H-1PV WITH AN ENHANCED FITNESS AND SUPERIOR ANTICANCER ACTIVITY

 #5
20250228928
2025-07-17

IMMUNE ENHANCEMENT AND INFECTIOUS DISEASE TREATMENT

 #6
20250127883
2025-04-24

METHOD FOR INHIBITING ZOPHOBAS MORIO BLACK WASTING DISEASE

 #7
20240384294
2024-11-21

BOCAPARVOVIRUS SMALL NONCODING RNA AND USES THEREOF

 #8
20240374662
2024-11-14

AAV Vectors Targeted to Oligodendrocytes

 #9
20240358820
2024-10-31

PROTOPARVOVIRUS COMPOSITIONS COMPRISING A PROTOPARVOVIRUS VARIANT VP1 CAPSID POLYPEPTIDE AND RELATED METHODS

 #10
20240263192
2024-08-08

THERAPEUTIC COMPOSITIONS COMPRISING TRANSCRIPTION FACTORS AND METHODS OF MAKING AND USING THE SAME

 #11
20240261395
2024-08-08

LYOPHILIZED NON-VIRAL DNA VECTOR COMPOSITIONS AND USES THEREOF

 #12
20240226264
2024-07-11

Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof

 #13
20240085419
2024-03-14

METHODS AND KITS FOR QUANTIFYING THE REMOVAL OF MOCK VIRUS PARTICLES FROM A PURIFIED SOLUTION

 #14
20240082329
2024-03-14

IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF

 #15
20230405110
2023-12-21

Canine Parvovirus

 #16
20230355741
2023-11-09

Feline Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

 #17
20230340032
2023-10-26

NOVEL ERYTHROPARVOVIRUS ASSOCIATED WITH RESPIRATORY DISTRESS IN EQUINE

 #18
20230302113
2023-09-28

Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof

 #19
20230295272
2023-09-21

Canine parvovirus nanobody CPV-VHH-E3 and application thereof

 #20
20230287358
2023-09-14

GENE THERAPIES FOR LYSOSOMAL DISORDERS

 #21
20230078668
2023-03-16

Methods of vaccine administration

 #22
20230051499
2023-02-16

Endothelium-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof

 #23
20220194991
2022-06-23

Recombinant canine parvovirus 2a VP2 and 2b VP2 antigen protein, and use thereof

 #24
20220154213
2022-05-19

small noncoding RNA and uses thereof

 #25
20220118083
2022-04-21

Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus

 #26
20220016236
2022-01-20

Recombinant porcine parvovirus antigenic protein and use thereof

 #27
20210292372
2021-09-23

COMPOSITIONS AND METHODS FOR TREATING, INCLUDING PREVENTING, PARVOVIRUS INFECTIONS AND RELATED DISEASES

 #28
20210128712
2021-05-06

Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof

 #29
20200405845
2020-12-31

Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy

 #30
20200384102
2020-12-10

Swine vaccine

 #31
20200345834
2020-11-05

Methods of manufacturing an immunogenic composition comprising a recombinant protein

 #32
20200331949
2020-10-22

D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation

 #33
20200316192
2020-10-08

Methods of vaccine administration

 #34
20200308554
2020-10-01

Gene therapies for lysosomal disorders

 #35
20200282080
2020-09-10

Gene therapies for lysosomal disorders

 #36
20200276335
2020-09-03

Gene therapies for lysosomal disorders

 #37
20200237900
2020-07-30

Endothelium-specific nucleic acid regulatory elements and methods and use thereof

 #38
20200071680
2020-03-05

Gene therapies for lysosomal disorders

 #39
20200060981
2020-02-27

CATIONIC NANOPARTICLES FOR ENHANCING INFECTIOUS CAPACITY OF LIVE VIRUSES

 #40
20200030438
2020-01-30

Vaccine against porcine parvovirus

 #41
20190353656
2019-11-21

Methods and kits for quantifying the removal of mock virus particles from a purified solution

 #42
20190338312
2019-11-07

Bocaparvovirus small noncoding RNA and uses thereof

 #43
20190338254
2019-11-07

Mutated rep encoding sequences for use in AAV production

 #44
20190328804
2019-10-31

AAV vectors targeted to oligodendrocytes

 #45
20190321463
2019-10-24

SCALABLE MANUFACTURING PLATFORM FOR VIRAL VECTOR PURIFICATION AND VIRAL VECTORS SO PURIFIED FOR USE IN GENE THERAPY

 #46
20190202867
2019-07-04

Compositions and methods for treating, including preventing, parvovirus infections and related diseases

 #47
20190000965
2019-01-03

Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof

 #48
20180282702
2018-10-04

Chimeric adeno-associated virus/ bocavirus parvovirus vector

 #49
20180147278
2018-05-31

Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof

 #50
20180133309
2018-05-17

Vaccine against porcine parvovirus

 #51
20180057839
2018-03-01

THERAPEUTIC COMPOSITIONS COMPRISING TRANSCRIPTION FACTORS AND METHODS OF MAKING AND USING THE SAME

 #52
20170360962
2017-12-21

Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies

 #53
20170348433
2017-12-07

Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies

 #54
20170274024
2017-09-28

AAV Vectors Targeted to Oligodendrocytes

 #55
20170192001
2017-07-06

Methods for evaluating viral clearance from a process solution employing mock viral particles

 #56
20170173146
2017-06-22

Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus (derzsy's disease)

 #57
20170165356
2017-06-15

Hybrid core feline vaccines

 #58
20170157244
2017-06-08

Vaccination response for immunodeficiency disorders or high cortisol

 #59
20170087244
2017-03-30

Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof

 #60
20170056492
2017-03-02

Porcine parvovirus

 #61
20170015712
2017-01-19

Compositions and methods for treating, including preventing, parvovirus infections and related diseases

 #62
20160297855
2016-10-13

Adeno-associated virus with site-directed mutagenesis and site-directed modification and preparation method and application thereof

 #63
20160228369
2016-08-11

Dry formulations of vaccines that are room temperature stable

 #64
20160206706
2016-07-21

Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy

 #65
20160068821
2016-03-10

Chimeric adeno-associated virus/ bocavirus parvovirus vector

 #66
20150335731
2015-11-26

Coating Method and Materials

 #67
20150306209
2015-10-29

CANINE PARVOVIRUS TYPE 2c ISOLATES AND METHODS OF USE

 #68
20150283230
2015-10-08

Porcine parvovirus 5B, methods of use and vaccine

 #69
20150246114
2015-09-03

Liquid stable virus vaccines

 #70
20150246113
2015-09-03

Porcine parvovirus 5A, methods of use and vaccine

 #71
20150238550
2015-08-27

AAV vectors targeted to oligodendrocytes

 #72
20150216964
2015-08-06

Attenuated parvovirus vaccine for Muscovy duck parvovirus and goose parvovirus (Derzsys disease)

 #73
20150182619
2015-07-02

Methods of vaccine administration

 #74
20150140035
2015-05-21

AUTOLOGOUS BIOLOGICAL CANCER VACCINE

 #75
20150072339
2015-03-12

Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles

 #76
20140322267
2014-10-30

ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION

 #77
20140227346
2014-08-14

Immunogenic combination compositions and uses thereof

 #78
20140170187
2014-06-19

Parvovirus Vp1 unique region polypeptides and compositions thereof

 #79
20140170180
2014-06-19

PORCINE PARVOVIRUS 5A, METHODS OF USE AND VACCINE

 #80
20140056942
2014-02-27

Liquid stable virus vaccines

 #81
20130273109
2013-10-17

Method for generating a parvovirus B19 virus-like particle

 #82
20130195913
2013-08-01

Live attenuated parvovirus

 #83
20130072548
2013-03-21

Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy

 #84
20130045235
2013-02-21

Autologous biological cancer vaccine

 #85
20130023034
2013-01-24

Mutated rep encoding sequences for use in AAV production

 #86
20120328652
2012-12-27

Recombinant attenuated parvovirus

 #87
20120263756
2012-10-18

Vaccines containing canine parvovirus genetic variants

 #88
20120121645
2012-05-17

SUPRALINGUAL VACCINES AND APPLICATORS

 #89
20110091502
2011-04-21

HUMAN PARVOVIRUS: HUMINK PARVOVIRUS

 #90
20110061136
2011-03-10

Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof

 #91
20100028379
2010-02-04

METHODS OF VACCINE ADMINISTRATION

 #92
20090098152
2009-04-16

Vaccines containing canine parvovirus genetic variants

 #93
20090010955
2009-01-08

Vaccines containing canine parvovirus genetic variants

 #94
20080311151
2008-12-18

Vaccine For Periodontal Disease

 #95
20080226670
2008-09-18

Canine combination vaccines

 #96
20080175860
2008-07-24

CANINE VACCINES

 #97
20070280964
2007-12-06

Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis

 #98
20070098744
2007-05-03

Probiotic enterococci for improved immunity

 #99
20060140976
2006-06-29

Trivalent vaccine with maternal anitbody transfer via the milk

 #100
20050281784
2005-12-22

Methods for administering recombinant adeno-associated virus virons to humans previously exposed to adeno-associated virus

 #101
20050232948
2005-10-20

Process for making an adjuvanted vaccine comprising host albumin

 #102
20050089533
2005-04-28

Canine vaccines against Bordetella bronchiseptica

 #103
20050010032
2005-01-13

Vaccine for periodontal disease